A detailed history of Verus Financial Partners, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Verus Financial Partners, Inc. holds 4,332 shares of JNJ stock, worth $629,309. This represents 0.08% of its overall portfolio holdings.

Number of Shares
4,332
Previous 4,518 4.12%
Holding current value
$629,309
Previous $660,000 6.36%
% of portfolio
0.08%
Previous 0.08%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$145.48 - $167.38 $27,059 - $31,132
-186 Reduced 4.12%
4,332 $702,000
Q2 2024

Aug 05, 2024

SELL
$144.38 - $157.78 $9,384 - $10,255
-65 Reduced 1.42%
4,518 $660,000
Q1 2024

May 07, 2024

SELL
$155.22 - $162.74 $36,631 - $38,406
-236 Reduced 4.9%
4,583 $724,000
Q4 2023

Feb 06, 2024

BUY
$145.6 - $158.88 $4,076 - $4,448
28 Added 0.58%
4,819 $755,000
Q3 2023

Oct 23, 2023

BUY
$155.75 - $174.48 $64,636 - $72,409
415 Added 9.48%
4,791 $746,000
Q2 2023

Jul 27, 2023

SELL
$154.35 - $166.11 $18,058 - $19,434
-117 Reduced 2.6%
4,376 $724,000
Q1 2023

May 05, 2023

SELL
$151.05 - $180.26 $45,315 - $54,078
-300 Reduced 6.26%
4,493 $696,000
Q4 2022

Feb 01, 2023

SELL
$160.2 - $179.79 $124,955 - $140,236
-780 Reduced 14.0%
4,793 $846,000
Q3 2022

Oct 31, 2022

SELL
$161.33 - $179.52 $69,049 - $76,834
-428 Reduced 7.13%
5,573 $925,000
Q2 2022

Aug 03, 2022

BUY
$168.19 - $186.01 $229,915 - $254,275
1,367 Added 29.5%
6,001 $1.03 Million
Q1 2022

Apr 15, 2022

SELL
$158.14 - $179.59 $13,758 - $15,624
-87 Reduced 1.84%
4,634 $834,000
Q4 2021

Jan 19, 2022

SELL
$155.93 - $173.01 $52,236 - $57,958
-335 Reduced 6.63%
4,721 $808,000
Q3 2021

Oct 29, 2021

BUY
$161.5 - $179.47 $15,988 - $17,767
99 Added 2.0%
5,056 $810,000
Q2 2021

Jul 23, 2021

BUY
$159.48 - $171.07 $55,180 - $59,190
346 Added 7.5%
4,957 $835,000
Q1 2021

Apr 27, 2021

SELL
$153.07 - $170.48 $47,604 - $53,019
-311 Reduced 6.32%
4,611 $754,000
Q4 2020

Feb 10, 2021

SELL
$137.11 - $157.38 $860,502 - $987,716
-6,276 Reduced 56.05%
4,922 $775,000
Q3 2020

Nov 03, 2020

BUY
$140.38 - $153.83 $961,603 - $1.05 Million
6,850 Added 157.54%
11,198 $1.67 Million
Q2 2020

Jul 31, 2020

SELL
$128.81 - $155.51 $10,562 - $12,751
-82 Reduced 1.85%
4,348 $611,000
Q1 2020

Apr 09, 2020

BUY
$111.14 - $153.99 $5,334 - $7,391
48 Added 1.1%
4,430 $581,000
Q4 2019

Jan 21, 2020

BUY
$127.5 - $146.44 $9,435 - $10,836
74 Added 1.72%
4,382 $639,000
Q3 2019

Oct 15, 2019

BUY
$126.95 - $142.14 $13,329 - $14,924
105 Added 2.5%
4,308 $557,000
Q2 2019

Aug 05, 2019

SELL
$131.15 - $144.24 $17,574 - $19,328
-134 Reduced 3.09%
4,203 $585,000
Q1 2019

Apr 19, 2019

BUY
$125.72 - $139.79 $71,408 - $79,400
568 Added 15.07%
4,337 $606,000
Q3 2018

Nov 09, 2018

SELL
$121.58 - $142.88 $27,963 - $32,862
-230 Reduced 5.75%
3,769 $521,000
Q2 2018

Jul 16, 2018

SELL
$119.4 - $131.76 $1,432 - $1,581
-12 Reduced 0.3%
3,999 $485,000
Q1 2018

Apr 23, 2018

BUY
$125.1 - $148.14 $25,020 - $29,627
200 Added 5.25%
4,011 $514,000
Q4 2017

Jan 29, 2018

BUY
$131.22 - $143.62 $11,153 - $12,207
85 Added 2.28%
3,811 $532,000
Q3 2017

Nov 03, 2017

BUY
$129.47 - $135.38 $482,405 - $504,425
3,726
3,726 $484,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $380B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Verus Financial Partners, Inc. Portfolio

Follow Verus Financial Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verus Financial Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Verus Financial Partners, Inc. with notifications on news.